Diabetes And Other Diseases Being Studied By Drug Firms And NIH

Posted: Feb 5 2014, 6:54am CST | by , Updated: Feb 5 2014, 7:56am CST, in News | Other Stuff


Diabetes Studied by Drug Firms and NIH
Getty Images
/* Story Top Left 2010 300x250, created 7/15/10 */ google_ad_slot = "8340327155";

The race has begun to find cures for such devastating diseases as diabetes, Alzheimer’s, rheumatoid arthritis and lupus. The NIH and drug firms are busy studying several other diseases besides diabetes. Finding the right medicines in the nick of time is the crucial order of the day.

Over ten large organizations that manufacture drugs have joined hands with the NIH. Their goal is to discover cures for some of the latest diseases and diabetes which resist a medical solution. Some of these are extremely tragic for sufferers and caretakers alike such as Alzheimer’s and also diabetes. 

A five year plan has been chalked out. The cracking of the code behind these degenerative diseases is what it is all about. The current input is $230 million. And although this is meager in comparison with the billions upon billions spent by the R&D labs around the world, it will be put to a different use. 

The objective for now is to combine forces in the form of the most brilliant minds, the best state-of-the-art materials and cutting edge research resources. This way the attainment of medicine and ameliorative methods will be speeded up. 

It is a completely alternative approach which is being used here. Especially, the twin menaces of Alzheimer’s and diabetes have appeared like a disaster on the horizon. Something has to be done to avert the health-quake they are liable to engender in the future. The curative drugs for these modern maladies can only be invented in the labs by a multipronged approach. 

In the past, most drugs didn’t reach the stage of being approved by the patent office. But now the NIH and various pharmaceutical companies will cooperate with each other. This is to create the miracle pills needed to end the symptoms of these ailments.   

Source: WSJ

You May Like


The Author

<a href="/latest_stories/all/all/20" rel="author">Sumayah Aamir</a>
Sumayah Aamir (Google+) has deep experience in analyzing the latest trends.




Leave a Comment

Share this Story

Follow Us
Follow I4U News on Twitter
Follow I4U News on Facebook

You Also Like


Read the Latest from I4U News